S84 Long-term efficacy of dupilumab: 3-year data of QUEST patients with moderate-to-severe asthma enrolled in LIBERTY ASTHMA TRAVERSE

Autor:	Arnaud Bourdin, Megan Hardin, Xuezhou Mao, David J. Lederer, Elizabeth Laws, Benjamin Ortiz, Ian D. Pavord, Leda Mannent, Alberto Papi, Nikhil Amin, Henrik Watz, M. Djandji, Christian Domingo, Michael E. Wechsler
Rok vydání:	2021
Předmět:	Moderate to severe Pediatrics medicine.medical_specialty business.industry medicine medicine.disease business Dupilumab Asthma Term (time)
Zdroj:	Biologics for asthma.
DOI:	10.1136/thorax-2021-btsabstracts.90
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b1de3413bbf290da3123571a85470893 https://doi.org/10.1136/thorax-2021-btsabstracts.90 Zobrazit plný text záznamu